Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insight and medication adherence in schizophrenia: An analysis of the CATIE trial
Julia Kim, Miracle Ozzoude, Shinichiro Nakajima, et al.
Neuropharmacology (2019) Vol. 168, pp. 107634-107634
Closed Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

A safety evaluation of aripiprazole in the treatment of schizophrenia
Adrian Preda, Bryan B. Shapiro
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 12, pp. 1529-1538
Closed Access | Times Cited: 58
Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study
Fanny Senner, Lena Hiendl, Susanne Bengesser, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
A new era for schizophrenia drug development – Lessons for the future
Kiri Granger, Michael Sand, Sheryl Caswell, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 7, pp. 103603-103603
Open Access | Times Cited: 15
Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults
Giovanna Cirnigliaro, Vera Battini, Michele Castiglioni, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 4, pp. 325-332
Closed Access | Times Cited: 5
The Beginning Psychotherapist's Companion
Jan Willer
Oxford University Press eBooks (2024)
Closed Access | Times Cited: 5
An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment
Joshua Mervis, Jenifer L. Vohs, Paul H. Lysaker
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 3, pp. 245-255
Closed Access | Times Cited: 20
Epilepsy in patients with schizophrenia: Pathophysiology and basic treatments
Naoto Adachi, Masumi Ito
Epilepsy & Behavior (2022) Vol. 127, pp. 108520-108520
Closed Access | Times Cited: 18
Impaired insight in schizophrenia is associated with higher frontoparietal cerebral blood flow: an arterial spin labeling study
Jianmeng Song, Edgardo Carmona-Torres, Yasaman Kambari, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Evaluation of the impact of refined nursing care on schizophrenia patients
Yuanling Zhang, Wenbin Liang, Jiachen Gui
Medicine (2025) Vol. 104, Iss. 3, pp. e40848-e40848
Open Access
The association between psychotic symptoms and suicidal ideation in a sample of patients with schizophrenia: The moderating effect of the frequency of suicidal thoughts
Abdallah Abu Khait, Austin Menger, Ghada Shahrour, et al.
Archives of Psychiatric Nursing (2025) Vol. 54, pp. 63-72
Closed Access
Implementation of the modified NAVIGATE program for early schizophrenia in Shanghai through the specialized hospital and community integration: A comparative study
Lihua Wang, Huijie Lu, Yihua Jiang, et al.
International Journal of Social Psychiatry (2025)
Closed Access
Insight and Its Trajectory: Predicting the Risk of Psychiatric Hospitalizations Among First-Episode Psychosis During the First Year of Coordinated Specialty Care
Hadar Hazan, Maria Ferrara, Toni Gibbs-Dean, et al.
Schizophrenia Bulletin (2025)
Closed Access
Psychotherapy Trends in the United States
Mark Olfson, Chandler McClellan, Samuel H. Zuvekas, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 5, pp. 483-492
Closed Access
From mechanism to applications: Advanced microneedles for clinical medicine
Yuqing Yang, Haifu Sun, Xiao Sun, et al.
Bioactive Materials (2025) Vol. 51, pp. 1-45
Closed Access
The Relationship Between Self-Stigma and Perceived Dignity Among Individuals With Schizophrenia: The Moderating Role of Insight Into Illness
Shuwen Lin, Yu-Chin Ma, Jason W. Beckstead, et al.
Journal of Psychosocial Nursing and Mental Health Services (2025), pp. 1-8
Closed Access
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial
Paul H. Lysaker, Peter J. Weiden, Xiaowu Sun, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Antipsychotic medication non-adherence and factors associated among patients with schizophrenia in eastern Ethiopia
Fethia Mohammed, Biftu Geda, Tesfaye Assebe Yadeta, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Deep transcranial magnetic stimulation for schizophrenia: a systematic review
Yu Mo, Zhan-Ming Shi, Xin-Hu Yang, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
Cortical thinning in relation to impaired insight into illness in patients with treatment resistant schizophrenia
Julia Kim, Jianmeng Song, Yasaman Kambari, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
Ilaria Riboldi, Daniele Cavaleri, Chiara Alessandra Capogrosso, et al.
Psychology Research and Behavior Management (2022) Vol. Volume 15, pp. 3915-3929
Open Access | Times Cited: 12
Shared decision making with schizophrenic patients: a randomized controlled clinical trial with booster sessions (DECIDE Study)
José Pérez-Revuelta, Francisco González‐Saiz, Juan Manuel Pascual-Paño, et al.
Patient Education and Counseling (2023) Vol. 110, pp. 107656-107656
Open Access | Times Cited: 7
Exploring barriers to seek mental health services among patients with severe mental illness and their caregivers in a modified assertive community treatment program: A qualitative thematic analysis
Praveen Jain, Samir Kumar Praharaj, Abhiram Narasimhan Purohith, et al.
Indian Journal of Psychiatry (2024) Vol. 66, Iss. 7, pp. 621-629
Open Access | Times Cited: 2
The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
Christoph U. Correll, Pin Xiang, Kaushik Sarikonda, et al.
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 3
Open Access | Times Cited: 2
Segmental hair analysis of olanzapine and N-desmethyl-olanzapine in postmortem hair from mentally ill patients by LC–MS/MS
Kamilla Nyborg Günther, Jytte Banner, Kristían Línnet, et al.
Journal of Pharmaceutical and Biomedical Analysis (2020) Vol. 190, pp. 113510-113510
Closed Access | Times Cited: 15
Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness
Niranjan Bidargaddi, G. Schrader, Hannah Myles, et al.
Australian & New Zealand Journal of Psychiatry (2021) Vol. 55, Iss. 10, pp. 976-982
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top